Can NAC Improve Fertility in Men and Women?

Discover how NAC improves sperm quality and ovulation in clinical trials. Get the evidence-based fertility insights you need.

April 3, 2026
Author
Superpower Science Team
Reviewed by
Julija Rabcuka
PhD Candidate at Oxford University
Creative
Jarvis Wang

You've probably heard that antioxidants are good for fertility, but most people don't realize that the specific antioxidant matters as much as the dose. N-acetylcysteine (NAC) has been studied in clinical trials for both male and female infertility, yet it remains far less discussed than vitamin D or CoQ10, despite evidence showing it can improve sperm parameters in men and support ovulation in women with polycystic ovary syndrome (2025 meta-analysis). The gap between what the research shows and what most people trying to conceive actually know about NAC is surprisingly wide (2025 non-rct observational study).

Whether NAC has a place in your fertility plan depends on your baseline oxidative stress status and the specific reproductive challenges you're facing. Superpower's baseline panel includes markers of inflammation and antioxidant capacity alongside the hormonal and metabolic context that determines how well your body can support conception.

Key Takeaways

  • NAC is a precursor to glutathione, the body's most important intracellular antioxidant.
  • Clinical trials show NAC improves sperm concentration, motility, and morphology in infertile men.
  • NAC combined with clomiphene citrate increases ovulation rates in women with PCOS.
  • The typical dose used in fertility studies is 600 mg daily for three to six months (2019 non-rct experimental).
  • NAC's fertility benefits stem from reducing oxidative stress in reproductive tissues.
  • Response to NAC is strongest in individuals with elevated oxidative stress at baseline.
  • NAC is generally well tolerated with minimal side effects at fertility-relevant doses.

What NAC Is and How It Functions as a Fertility Antioxidant

N-acetylcysteine is a modified form of the amino acid cysteine, with an acetyl group attached that improves its stability and absorption. Once inside cells, NAC is converted to cysteine, which is the rate-limiting substrate for the synthesis of glutathione. Glutathione is a tripeptide composed of cysteine, glutamate, and glycine, and it functions as the primary intracellular antioxidant, neutralizing reactive oxygen species (ROS) that would otherwise damage DNA, proteins, and lipid membranes.

In the context of fertility, oxidative stress is a well-documented contributor to both male and female infertility. In men, excessive ROS production in the seminal plasma damages sperm DNA, impairs motility, and reduces the sperm's ability to fertilize an egg. In women, oxidative stress in the ovarian follicle can compromise oocyte quality, disrupt normal follicular development, and interfere with the hormonal signaling required for ovulation. NAC addresses these issues not by acting as a direct antioxidant in the bloodstream, but by replenishing intracellular glutathione stores, which then neutralize ROS at the source.

NAC also has direct mucolytic properties, meaning it breaks down disulfide bonds in mucus, which is why it's used clinically for respiratory conditions. In fertility applications, this mechanism may improve cervical mucus quality, though the evidence for this effect is less robust than the evidence for its antioxidant role.

What the Clinical Evidence Shows for NAC and Male Fertility

Multiple randomized controlled trials have examined NAC supplementation in men with idiopathic infertility, meaning infertility without an identifiable anatomical or hormonal cause. A 2019 meta-analysis published in Reproductive Biology and Endocrinology reviewed studies in which men took 600 mg of NAC daily for three to six months. The pooled results showed significant improvements in sperm concentration, total motility, and progressive motility compared to placebo. Specifically, sperm concentration increased by an average of 4.5 million per milliliter, and progressive motility improved by approximately 4 percentage points.

The mechanism behind these improvements is straightforward: oxidative stress in the testes and seminal plasma damages sperm membranes and DNA. NAC supplementation increases glutathione levels in seminal fluid, which neutralizes ROS and protects sperm from oxidative damage. One study measured seminal glutathione levels before and after NAC supplementation and found a significant increase, correlating with improved sperm parameters.

The evidence is strongest in men with elevated oxidative stress markers at baseline. Men with normal semen parameters and low oxidative stress do not show the same degree of improvement, which suggests that NAC is correcting a deficit rather than enhancing function beyond normal levels. This distinction is important: NAC is not a performance enhancer for men with healthy sperm; it is a corrective intervention for men whose sperm quality is compromised by oxidative damage.

Effect sizes in these trials are modest but clinically meaningful. A 4-point improvement in progressive motility may not sound dramatic, but in the context of assisted reproductive technology, where every percentage point of motility can affect fertilization rates, these gains matter. Live birth data is limited, as most studies report surrogate markers like sperm parameters rather than pregnancy outcomes, but the improvements in sperm quality are consistent across multiple trials.

Sperm DNA fragmentation and NAC

Sperm DNA fragmentation is a marker of oxidative damage that standard semen analysis does not capture. High DNA fragmentation is associated with lower fertilization rates, higher miscarriage rates, and poorer outcomes in both natural conception and in vitro fertilization (2024 meta-analysis). Some studies have measured DNA fragmentation before and after NAC supplementation and found significant reductions, suggesting that NAC's protective effect extends beyond motility and concentration to the integrity of the genetic material itself.

How NAC Supports Ovulation and Fertility in Women with PCOS

Polycystic ovary syndrome is one of the most common causes of anovulatory infertility in women. Women with PCOS often have elevated oxidative stress markers, insulin resistance, and hormonal imbalances that interfere with normal follicular development and ovulation. NAC has been studied as an adjunct to ovulation induction medications, particularly clomiphene citrate, in women with PCOS who do not respond to clomiphene alone.

A 2007 randomized controlled trial published in Fertility and Sterility compared clomiphene plus NAC (1,200 mg daily) to clomiphene plus placebo in women with clomiphene-resistant PCOS (2019 rct). The NAC group had significantly higher ovulation rates (49% vs. 1%) and pregnancy rates (21% vs. 0%). The mechanism is thought to involve NAC's ability to improve insulin sensitivity and reduce oxidative stress in the ovarian follicle, both of which are disrupted in PCOS.

A 2025 systematic review and meta-analysis in the journal Nutrients evaluated multiple trials of NAC in women with PCOS and found that NAC supplementation significantly increased progesterone levels, improved endometrial thickness, and reduced luteinizing hormone (LH) levels. These hormonal changes are consistent with improved ovulatory function. The review also noted that NAC was more effective than metformin in some studies, though the evidence base for metformin is larger and more established.

Not all studies have shown benefit (2020 meta-analysis). A 2017 trial published in the Journal of Obstetrics and Gynaecology found that NAC did not improve ovulation rates in women undergoing intrauterine insemination, suggesting that the benefit may be specific to certain populations or treatment protocols. The inconsistency in results may reflect differences in baseline oxidative stress, insulin resistance, or the specific ovulation induction protocol used.

NAC and oocyte quality

Beyond ovulation induction, some research suggests that NAC may improve oocyte and embryo quality in women undergoing in vitro fertilization (2022 rct). A study in women with advanced maternal age found that NAC supplementation during ovarian stimulation improved the number of high-quality embryos, though the study was small and requires replication. The proposed mechanism is that NAC reduces oxidative stress in the follicular fluid, which surrounds the developing oocyte and provides the biochemical environment for maturation.

The Biochemical Pathway: How NAC Restores Glutathione and Protects Reproductive Cells

NAC's role in fertility is inseparable from its role as a glutathione precursor. Glutathione is synthesized in two steps:

  • First, cysteine combines with glutamate to form gamma-glutamylcysteine, catalyzed by the enzyme glutamate-cysteine ligase.
  • Second, glycine is added to form glutathione, catalyzed by glutathione synthetase.

Cysteine availability is the rate-limiting step, meaning that if cysteine is in short supply, glutathione synthesis slows down. NAC provides a bioavailable source of cysteine that bypasses the limitations of dietary cysteine intake. Once absorbed, NAC is deacetylated to cysteine, which enters the glutathione synthesis pathway. Glutathione then functions as a reducing agent, donating electrons to neutralize ROS such as hydrogen peroxide, superoxide, and hydroxyl radicals. In the process, glutathione is oxidized to glutathione disulfide (GSSG), which is then reduced back to glutathione by the enzyme glutathione reductase, using NADPH as a cofactor.

In reproductive tissues, this cycle is critical. Sperm are particularly vulnerable to oxidative damage because their membranes are rich in polyunsaturated fatty acids, which are easily oxidized. Oocytes are vulnerable because they have limited antioxidant defenses compared to other cell types, and oxidative damage accumulates over time, which is one reason why oocyte quality declines with age. By restoring glutathione levels, NAC provides the biochemical machinery needed to neutralize ROS before they cause irreversible damage.

NAC also has a secondary mechanism: it can directly scavenge certain ROS through its thiol group, though this effect is less significant than its role as a glutathione precursor. The thiol group can react with free radicals, forming stable disulfide bonds and preventing the radicals from damaging cellular structures. This direct antioxidant activity is modest compared to the amplification effect of increasing intracellular glutathione, but it contributes to NAC's overall protective effect.

Dose, Form, and Timing: What the Fertility Studies Actually Used

Dose

The most commonly studied dose of NAC for fertility is 600 mg daily, taken for a minimum of three months (2021 meta-analysis). Some studies have used 1,200 mg daily, divided into two doses, particularly in women with PCOS (2022 rct). Higher doses have not been shown to produce significantly better outcomes, and doses above 1,800 mg per day are associated with gastrointestinal side effects such as nausea and diarrhea (2019 rct). The 600 mg dose appears to be the sweet spot: high enough to meaningfully increase glutathione levels, low enough to be well tolerated.

The duration of supplementation matters. Sperm take approximately 74 days to mature, which means that improvements in sperm parameters are not visible until at least two to three months of supplementation. Similarly, oocyte quality improvements require time for the antioxidant effects to accumulate in the ovarian follicle. Most fertility trials use a three- to six-month supplementation period, and shorter durations have not been adequately studied.

Form

NAC is available as an oral supplement in capsule or tablet form. There is no evidence that one form is superior to another in terms of bioavailability. NAC is also available as an effervescent tablet, which some people find easier to tolerate, though the absorption profile is similar. Intravenous NAC is used in clinical settings for acetaminophen overdose but is not relevant to fertility applications.

Timing

NAC can be taken with or without food, though taking it with food may reduce gastrointestinal side effects. There is no evidence that timing within the day affects efficacy. For women undergoing ovulation induction or IVF, NAC is typically started at the beginning of the treatment cycle and continued through ovulation or egg retrieval. For men, NAC should be started at least three months before a planned conception attempt or semen analysis to allow time for sperm maturation.

Combinations

NAC is often combined with other antioxidants in fertility protocols, including vitamin C, vitamin E, and CoQ10. The rationale is that these antioxidants work through different mechanisms and may have synergistic effects. However, there is limited evidence that combining NAC with other antioxidants produces better outcomes than NAC alone. One exception is the combination of NAC with clomiphene citrate in women with PCOS, where the evidence for synergy is strong.

Who Benefits Most from NAC, and Who Should Exercise Caution

NAC is most likely to improve fertility outcomes in individuals with elevated oxidative stress at baseline. This includes men with idiopathic infertility, particularly those with low sperm motility or high DNA fragmentation. It also includes women with PCOS, who often have elevated oxidative stress markers and insulin resistance. Women with advanced maternal age may also benefit, as oxidative stress in the ovarian follicle increases with age, though the evidence for this population is less robust.

Individuals with normal fertility parameters and low oxidative stress are less likely to see meaningful improvements. NAC is not a fertility enhancer in the absence of oxidative damage; it is a corrective intervention.

Populations who should exercise caution

NAC is generally well tolerated, but there are some populations who should use it cautiously or avoid it:

  • People with asthma should be aware that NAC can trigger bronchospasm in rare cases, though this is more common with inhaled NAC than oral supplementation.
  • People taking nitroglycerin or other nitrate medications should avoid NAC, as the combination can cause severe hypotension.
  • NAC can interact with certain chemotherapy drugs, so individuals undergoing cancer treatment should consult their oncologist before using it.
  • Pregnant women should discuss NAC use with their healthcare provider, as most fertility trials discontinue NAC once pregnancy is confirmed.

Baseline testing and individual variation

Not everyone with infertility has elevated oxidative stress, and not everyone with elevated oxidative stress will respond to NAC. Baseline testing of oxidative stress markers, such as high-sensitivity C-reactive protein or malondialdehyde, can help identify individuals who are most likely to benefit. Similarly, testing ferritin and other markers of inflammation can provide context for interpreting oxidative stress levels.

Testing Your Oxidative Stress Status and Tracking NAC's Effect

The challenge with NAC supplementation is that oxidative stress is not routinely measured in standard fertility workups. Serum markers of oxidative stress, such as malondialdehyde or 8-hydroxy-2'-deoxyguanosine, are available in research settings but are not widely accessible in clinical practice. However, indirect markers can provide useful information.

High-sensitivity C-reactive protein is a marker of systemic inflammation, which is closely linked to oxidative stress. Elevated hs-CRP suggests that the body is under inflammatory stress, which often correlates with increased ROS production. Ferritin is another marker that can be informative: while ferritin is primarily a marker of iron stores, it is also an acute-phase reactant that rises in response to inflammation. The ferritin-to-CRP ratio can help distinguish true iron overload from inflammation-driven ferritin elevation.

For men, semen analysis is the most direct way to track NAC's effect. Sperm concentration, motility, and morphology should be measured before starting NAC and again after three months of supplementation. Sperm DNA fragmentation testing, if available, provides additional information about oxidative damage. For women, tracking ovulation through basal body temperature, ovulation predictor kits, or serum progesterone levels can help assess whether NAC is improving ovulatory function.

Hormonal markers are also relevant. In women with PCOS, NAC supplementation should ideally be accompanied by monitoring of fasting insulin, glucose, and testosterone levels, as improvements in these markers suggest that NAC is addressing the underlying metabolic dysfunction. In men, testosterone and sex hormone-binding globulin can provide context for interpreting changes in sperm parameters.

Getting a Clear Picture of Your Fertility Baseline Before You Supplement

NAC is one of the more evidence-based fertility supplements, but whether it's the right intervention for you depends on your baseline oxidative stress status, your specific fertility challenges, and the broader hormonal and metabolic context. Supplementing without testing is a gamble; testing first transforms it into a targeted intervention. Superpower's 100+ biomarker panel includes markers of inflammation, antioxidant capacity, and the hormonal and metabolic factors that determine how well your body can support conception, giving you the data you need to decide whether NAC is worth adding to your protocol.

Latest